Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 4
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Bowles, Erin J. Aiello Gao, Hongyuan Brandzel, Susan Bradford, Susan Carol and Buist, Diana S.M. 2016. Comparative effectiveness of two outreach strategies for cervical cancer screening. Preventive Medicine, Vol. 86, p. 19.

    Simon-Tuval, Tzahit Neumann, Peter J. and Greenberg, Dan 2016. Cost-effectiveness of adherence-enhancing interventions: a systematic review. Expert Review of Pharmacoeconomics & Outcomes Research, Vol. 16, Issue. 1, p. 67.

    Bradley, Declan T Treanor, Charlene McMullan, Colin Owen, Tracy Graham, Adele and Anderson, Diane 2015. Reasons for non-participation in the Northern Ireland Bowel Cancer Screening Programme: a qualitative study: Table 1. BMJ Open, Vol. 5, Issue. 9, p. e008266.

    Senore, Carlo Inadomi, John Segnan, Nereo Bellisario, Cristina and Hassan, Cesare 2015. Optimising colorectal cancer screening acceptance: a review. Gut, Vol. 64, Issue. 7, p. 1158.

  • International Journal of Technology Assessment in Health Care, Volume 29, Issue 3
  • July 2013, pp. 261-268


  • Paula Cronin (a1), Stephen Goodall (a1), Trevor Lockett (a2), Christine M. O'Keefe (a3), Richard Norman (a1) and Jody Church (a1)
  • DOI:
  • Published online: 19 June 2013

Objectives: The aim of this study is to evaluate the cost-effectiveness of a patient-direct mailed advance notification letter on participants of a National Bowel Cancer Screening Program (NBCSP) in Australia, which was launched in August 2006 and offers free fecal occult blood testing to all Australians turning 50, 55, or 65 years of age in any given year.

Methods: This study followed a hypothetical cohort of 50-year-old, 55-year-old, and 65-year-old patients undergoing fecal occult blood test (FOBT) screening through a decision analytic Markov model. The intervention compared two strategies: (i) advance letter, NBCSP, and FOBT compared with (ii) NBCSP and FOBT. The main outcome measures were life-years gained (LYG), quality-adjusted life-years (QALYs) gained and incremental cost-effectiveness ratio.

Results: An advance notification screening letter would yield an additional 54 per 100,000 colorectal cancer deaths avoided compared with no letter. The estimated cost-effectiveness was $3,976 per LYG and $6,976 per QALY gained.

Conclusions: An advance notification letter in the NBCSP may have a significant impact on LYG and cancer deaths avoided. It is cost-effective and offers a feasible strategy that could be rolled out across other screening program at an acceptable cost.

Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

3.JS Mandel , TR Church , JH Bond , et al.The effect of fecel occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343:16031607.

4.G Salkeld , G Young , L Irwig , M Haas , P Glasziou . Cost-effectiveness analysis of screening by faecal occult blood testing for colorectal cancer in Australia. Aust N Z J Public Health. 1996;20:138143.

8.SR Cole , A Smith , C Wilson , et al.An advance notification letter increases participation in colorectal cancer screening. J Med Screen. 2007;14:7375.

9.JK Lee , EJ Groessl , TG Ganiats , SB Ho . Cost-effectiveness of a mailed educational reminder to increase colorectal cancer screening. BMC Gastroenterol. 2011;11:93.

10.TD Sequist , C Franz , JZ Ayanian . Cost-effectiveness of patient mailings to promote colorectal cancer screening. Med Care. 2010;48:553557.

11.BA O'Leary , JK Olynyk , AM Neville , CF Platell . Cost-effectiveness of colorectal cancer screening: Comparison of community-based flexible sigmoidoscopy with fecal occult blood testing and colonoscopy. J Gastroenterol Hepatol. 2004;19:3847.

13.DA Lieberman , DG Weiss , JH Bond , et al.Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med. 2000;343:162168.

15.TJ Mapp , JD Hardcastle , SM Moss , MH Robinson . Survival of patients with colorectal cancer diagnosed in a randomized controlled trial of faecal occult blood screening. Br J Surg. 1999;86:12861291.

16.MH Robinson , JD Hardcastle , SM Moss , et al.The risks of screening: Data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer. Gut. 1999;45:588592.

19.F Loeve , ML Brown , R Boer , et al.Endoscopic colorectal cancer screening: A cost-saving analysis. J Natl Cancer Inst. 2000;92:557563.

20.H Brenner , L Altenhofen , A Katalinic , I Lansdorp-Vogelaar , M Hoffmeister . Sojourn time of preclinical colorectal cancer by sex and age: Estimates from the German National Screening Colonoscopy Database. Am J Epidemiol. 2011;174:11401146.

22.MA Parker , MH Robinson , JH Scholefield , JD Hardcastle . Psychiatric morbidity and screening for colorectal cancer. J Med Screen. 2002;9:710.

37.A Smith , GP Young , SR Cole , P Bampton . Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer. 2006;107:21522159.

28.B George , A Harris , A Mitchell . Cost-effectiveness analysis and the consistency of decision making: Evidence from pharmaceutical reimbursement in Australia (1991 to 1996). Pharmacoeconomics. 2001;19:11031109.

29.JM Lane , E Chow , GP Young , N Good . Immunochemical testing in a colonoscopic surveillance program speeds detection of colorectal neoplasia. Gastroenterology. 2010;139:19181926.

30.K Howard , G Salkeld , L Irwig , BA Adelstein . High participation rates are not necessary for cost-effective colorectal cancer screening. J Med Screen. 2005;12:96102.

31.J King , G Fairbrother , C Thompson , DL Morris . Colorectal cancer screening: Optimal compliance with postal faecal occult blood test. Aust N Z J Surg. 1992;62:714719.

32.TN Chirikos , LK Chistman , BS Seft Hunter , MD Roetzheim . Cost-effectiveness of an intervention to increase cancer screening in primary care settings. Prev Med. 2004;39:230238.

33.WS Atkin , BC Morson , J Cuzick . Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med. 1992;326:658662.

40.JA McLeish , VJ Thursfield , GG Giles . Survival from colorectal cancer in Victoria: 10-year follow up of the 1987 management survey. ANZ J Surg. 2002;72:352356.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

International Journal of Technology Assessment in Health Care
  • ISSN: 0266-4623
  • EISSN: 1471-6348
  • URL: /core/journals/international-journal-of-technology-assessment-in-health-care
Please enter your name
Please enter a valid email address
Who would you like to send this to? *